Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'd been wondering for a while whether the FDA shut down affected approvals of new drugs and had been flummoxed for a while with my Google skills not finding anything. Well, today I found the relevant FDA page and some evidence to support the theory:
Go here and stick in February 2018 and compare against February 2019.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process
We see the FDA approved twice as many new drugs in Feb 2018 than 2019 (16 vs 9). The government shutdown lasted for roughly all of January. Food for thought.
interesting wackybaccy.i have not previously subscribed to the shutdown theory as it smacked to me of straw clutching.however the figures you have highlighted do seem to indicate that there may well be something in it.going to be an interesting few weeks now!
Whist a theory let’s not get carried away, it could be as simple as that period less drugs where suitable. If you compare other parts of the year you’ll see similar patterns. I guess it simply depends on what drugs are sent to the FDA in any given period. One month you could get a load of rubbish next month could be all superb. Luck of the draw. However I do think it will get to market, it’s just a case of sooner or later, play with caution at this stage for me. Ps....not trying to put dampener on things lol ;) just a cautious guy ;) Enjoy the bank holiday all and let’s keep fingers crossed for the next month
wouldn't argue with that at all spike.its just a possibility.originally i would have given it no more that 1/10 as a reason but now i would give it 2 or perhaps 3 out of 10 but its all just speculation.good to know we will have some facts in the not too distant future.
What was the outcome of the repayment of loan notes at $7mil due 18th May? I know they were looking at the raise option but wasn’t this for “working capital”?
It is a small sample, so I have gone over the last 2 years of approved drug applications and come up with the following graphs (I love data entry):
https://imgur.com/a/SkTFvzz
I couldn't get a list of CRLs by month because it seems the information is not available however that would provide a more complete picture:
https://www.fiercebiotech.com/biotech/fda-chief-gottlieb-backs-away-from-plan-to-publish-crls